Related Experiment Video
Updated: May 16, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Development and Validation of a Canadian Prediction Equation for Incident CKD Using Population-Based, Administrative
Manish M Sood1,2,3,4, Stephanie N Dixon2,5,6, Sarah E Bota2,6
1Division of Nephrology, Department of Medicine, University of Ottawa, ON, Canada.
Background:
Identifying individuals at risk for incident chronic kidney disease (CKD; estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2) could aid in prevention and disease surveillance.
Objective:
Develop and validate prediction equations to identify individuals at risk of incident CKD using routinely collected administrative data with and without urine albumin-to-creatinine ratio (ACR).
Design:
This is a retrospective cohort study using administrative data.
Setting:
This study was conducted in Manitoba and Ontario, Canada.
Patients:
This study included 413 948 adults (18 or older) with an eGFR > 70 mL/min/1.73 m2 from Manitoba (derivation cohort; 2006-2016) with external validation in 7 747 513 adults from Ontario, Canada.
Measurements:
Routinely available variables (demographics, comorbidities, laboratory values) in administrative data sets were used to predict the outcome of incident CKD (stage G3+) defined by a single outpatient eGFR measure <60 mL/min/1.73 m2 during and up to 10 years of follow-up. In an additional analysis, we defined incident CKD using repeat eGFR measures.
Methods:
Time-to-event models, accounting for the competing risk of death, were used to predict new-onset CKD from one to nine years with a data-driven model reduction. Prediction equations stratifying individuals with and without ACR measurements were derived internally and externally validated.
Results:
Among individuals from Manitoba [53% women, mean (SD) age 51 (17), mean (SD) baseline eGFR 95 (14) mL/min/1.73 m2, median (interquartile range) ACR 0.7 mg/mmol (1-3)], incident CKD occurred in 11.4% during a median follow-up time of 4.5 (Q1 = 2.3, Q3 = 7.6) years of follow-up. The final model included six variables (age, sex, baseline eGFR, hemoglobin, hypertension, and diabetes) and yielded a five-year area under the curve of 86.0 (no ACR) and 80.2 (with ACR). Model performance was excellent in external validation.
Limitations:
Only individuals with measures of all model predictors (complete case analysis) were included.
Conclusion:
Equations using routinely collected population-level, administrative data variables can accurately predict the onset of CKD with or without ACR.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance